Regulation of Angiogenesis and Angiogenic Factors by Cardiovascular Medications

E-ISSN： 1873-4286|13|20|2113-2117

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.20, 2007-07, pp. : 2113-2117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular disease

By Rebar Edward J

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 7, 2004-07 ,pp. : 829-839

Informa Healthcare

Access to resources Recommend Favorite

Pro-angiogenic Molecules for Therapeutic Angiogenesis

Current Medicinal Chemistry, Vol. 24, Iss. 31, 2017-10 ,pp. : 3413-3432

Bentham Science Publishers

Access to resources Recommend Favorite

Aspirin Resistance: Possible Roles of Cardiovascular Risk Factors, Previous Disease History, Concomitant Medications and Haemorrheological Variables

By Feher Gergely Koltai Katalin Papp Elod Alkonyi Balint Solyom Alexander Kenyeres Peter Kesmarky Gabor Czopf Laszlo Toth Kalman

Drugs & Aging, Vol. 23, Iss. 7, 2006-01 ,pp. : 559-567

Adis International

Access to resources Recommend Favorite

Roles of Cardiovascular Risk Factors in Endothelial Nitric Oxide Synthase Regulation: An Update

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3563-3578

Bentham Science Publishers

Access to resources Recommend Favorite

A401–A406 Cardiovascular/Angiogenesis

Cells Tissues Organs, Vol. 166, Iss. 1, 2000-02 ,pp. : 69-71

Karger

Access to resources Recommend Favorite